Pergolide mesylate and idiopathic Parkinson disease
- 1 October 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 32 (10), 1175
- https://doi.org/10.1212/wnl.32.10.1175
Abstract
We studied the effects of pergolide mesylate in an open trial of 23 patients with idiopathic Parkinson disease (PD). All had suffered from loss of efficacy or dose-limiting side effects on current antiparkinsonian regimens. On pergolide therapy, improvement, which was maintained for 6 months, was noted in some parkinsonian features in all 23 patients. All patients suffering from on-off phenomenon were helped by pergolide. Significant side effects were not encountered. Pergolide is useful in the treatment of PD.This publication has 9 references indexed in Scilit:
- Treatment of advanced Parkinson disease with pergolideNeurology, 1981
- Lisuride in parkinsonismNeurology, 1981
- The effect of bromocriptine (BCT) on the on-off phenomenonJournal of Neural Transmission, 1981
- Long‐term efficacy of bromocriptine in Parkinson diseaseNeurology, 1980
- Analysis of the clinical problems in parkinsonism and the complications of long‐term levodopa therapyNeurology, 1979
- The role of bromocriptine in the treatment of parkinsonismNeurology, 1979
- Lergotrile in the treatment of parkinsonismNeurology, 1978
- Five Years' Treatment of Parkinson's Disease with LevodopaAnnals of Internal Medicine, 1975
- ParkinsonismNeurology, 1967